CD3-ε, often denoted as CD3 epsilon, represents a vital component of the CD3 complex that is intricately linked with the T-cell receptor (TCR) on the surface of T lymphocytes. This complex holds paramount importance in the realm of immunology, chiefly because it orchestrates the interactions between T cells and antigens, thereby acting as a bridge to connect external antigenic stimuli with the internal cellular machinery. As a subset of this complex, CD3-ε shoulders the responsibility of stabilizing the entire assembly, with its unique structure, which includes immunoreceptor tyrosine-based activation motifs (ITAMs), playing a pivotal role in signal transduction. When antigens bind to the TCR, they initiate a cascade of cellular events, with CD3-ε at the forefront, translating these external signals into a coherent intracellular response that culminates in T-cell activation.
In the context of chemical entities, activators targeting CD3-ε are designed to amplify its inherent activity within the TCR/CD3 framework. These activators operate on multiple fronts: they might elevate the expression levels of CD3-ε, bolster its signaling prowess, or further cement its position within the TCR/CD3 structure. By modulating the functional dynamics of CD3-ε, these activators can influence the magnitude and specificity of the T-cell response. The realm of CD3-ε activators is vast and diverse, with each molecule bringing its unique mode of action to the table. Understanding these activators is akin to decoding the subtle nuances of T-cell signaling, offering a deep dive into the sophisticated mechanisms that underpin the adaptive immune response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences T-cell differentiation and might modulate CD3-ε expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can modulate T-cell activation and might influence CD3-ε expression. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Immunosuppressant that inhibits purine synthesis in T cells, potentially affecting CD3-ε expression. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Modulates T-cell activation and could influence CD3-ε expression. | ||||||
Fingolimod | 162359-55-9 | sc-507334 | 10 mg | $160.00 | ||
Sphingosine-1-phosphate receptor modulator affecting T-cell trafficking. Might indirectly influence CD3-ε expression. | ||||||
6-Mercaptopurine | 50-44-2 | sc-361087 sc-361087A | 50 mg 100 mg | $72.00 $104.00 | ||
Immunosuppressant affecting T-cell proliferation, which might modulate CD3-ε expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase and affects T-cell activation, potentially influencing CD3-ε expression. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Immunosuppressant affecting purine synthesis in T cells, potentially affecting CD3-ε expression. | ||||||